In relation to recent media comments relating to its
commercialisation discussions UK company GW Pharmaceuticals said in
a statement this week that it has consistently stated its
commercial strategy 'to be to enter into partnerships...
As in-licensing opportunities are reduced and competition for
market share in Japan increases with the rising penetration of
western pharma companies, domestic mid-cap players must alter their
strategies to remain independent, writes...
US company Molecular Devices, a supplier of bioanalytical
measurement systems, announced its revenues and earnings for the
quarter and year ended 31 December, 2002. Revenues for the fourth
quarter of 2002 were a healthy $30.2 million,...
German chemicals company Degussa has sold its Frankfurt/Main-based
biopharmaceutical company Zentaris to Canadian firm AEterna
Laboratories for approximately €50 million, the company said last
week. The move marks the much-talked...